Apeiron Investment Group Ltd. 4
4 · ATAI Life Sciences N.V. · Filed Apr 17, 2024
Insider Transaction Report
Form 4
Apeiron Investment Group Ltd.
10% Owner
Transactions
- Other
Convertible Notes
2024-04-15−147,950→ 0 total(indirect: By Apeiron Investment Group Ltd.)→ Common Shares (2,367,200 underlying) - Other
Convertible Notes
2024-04-15+147,950→ 147,950 total(indirect: By Apeiron Investment Group Ltd.)From: 2024-04-15Exp: 2025-09-30→ Common Shares (2,367,200 underlying)
Footnotes (4)
- [F1]The conversion price for the Convertible Notes is EUR 17.00 per note.
- [F2]Represents an exchange of Convertible Notes issued by ATAI Life Sciences AG for Convertible Notes issued by the Issuer with substantially similar terms and economics.
- [F3]Each Convertible Note bears a notional principal amount of EUR 1.00.
- [F4]The reportable securities are held by Apeiron Investment Group Ltd. ("Apeiron"). Christian Angermayer, as the majority shareholder of Apeiron, may be deemed to beneficially own the securities.